News in Numbers

The osteoporosis market is expected to reach a valuation of $17.9bn across the seven major markets by 2033, as per a GlobalData analysis.

Emergent BioSolutions has received contract modifications worth $250m from the US Department of Health and Human Services for the supply of four medical countermeasures including anthrax and smallpox vaccines.

Alimera Sciences shares jumped 77% after being acquired by ANI Pharmaceuticals.

As per the World Health Organization, 44% of 28,292 applications for patients seeking medical care outside the West Bank have been denied or remain pending, between October 2023 and May 2024.

Boehringer Ingelheim and AstraZeneca have introduced a $35 monthly price cap on inhalers as of 1 June, 2024, with GSK to follow suit no later than 1 January, 2025.